Laurion Capital Management LP Precision Biosciences Inc Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.22 - $40.8 $16,185 - $541,293	13,267 New	13,267 $17,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $154,694 - $449,286	-134,517 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.96 - $7.76 $39,270 - $102,951	-13,267 Reduced 8.98%	134,517 $414,000
Q2 2021 Aug 13, 2021	SELL	$8.07 - $12.52 $639,240 - $991,734	-79,212 Reduced 34.9%	147,784 $1.85 Million
Q1 2020 May 14, 2020	SELL	$5.05 - $15.01 $1.47 Million - $4.36 Million	-290,788 Reduced 56.16%	226,996 $1.37 Million
Q1 2019 May 08, 2019	BUY	$17.44 - $17.95 $9.03 Million - $9.29 Million	517,784 New	517,784 $9.3 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $554M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.